The Cognigram™ solution detects very subtle changes in cognition that could signify the early stages of dementia. Because neurological changes begin 20 or more years before cognitive symptoms appear¹, early detection of dementia is critical.
It is important [for physicians] to determine whether there is objective evidence of cognitive decline and, if so, the degree of the decline…¹
Long-term monitoring of cognitive function with the Cognigram system offers primary care physicians a simple tool with high test-retest reliability, no practice effect.²
The Cognigram Solution reveals subtle changes in cognitive function over 36 months – even in at-risk patients who have not yet been diagnosed with Mild Cognitive Impairment (MCI).²
¹ Alzheimers Dement 2017;13:325-373.
² Lim et al., Arch Clin Neuropsychol. 2015 Feb;30(1):49-58
How will healthcare providers manage increasing resource demands needed to care for patients with cognitive impairment? Rapid and reliable cognitive assessment can play a pivotal role in the growing brain health epidemic.
Join Prof. Paul Maruff, Cogstate Chief Scientific Officer and Dr. Sharon Cohen, Toronto Memory Program Medical Director as they discuss the science and application of the Cognigram™ solution, and how it offers clinicians a new tool in managing patients with memory and cognitive impairment.
Recorded from our live webinar on December 7, 2017